ARTICLE | Clinical News
Zinplava bezlotoxumab regulatory update
October 31, 2016 7:00 AM UTC
FDA approved a BLA for Zinplava bezlotoxumab from Merck to reduce recurrence of Clostridium difficile infection (CDI) in adults receiving antibacterial drug treatment of CDI and are at high risk for r...